NLRP3 inflammasome activation in murine alveolar macrophages and related lung pathology is associated with MWCNT nickel contamination

References

• Arend WP, Palmer G, Gabay C. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:20–38.
   PubMed Web of Science ®Google Scholar
• Bonner JC. 2010. Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc 7:138–141.
   PubMedGoogle Scholar
• Boya P, Kroemer G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene 27:6434–6451.
   PubMed Web of Science ®Google Scholar
• Buford MC, Hamilton RF Jr, Holian A. 2007. A comparison of dispersing media for various engineered carbon nanoparticles. Part Fibre Toxicol 4:6.
   PubMedGoogle Scholar
• Caicedo MS, Desai R, McAllister K, Reddy A, Jacobs JJ, Hallab NJ. 2009. Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity. J Orthop Res 27:847–854.
   PubMed Web of Science ®Google Scholar
• Cassel SL, Joly S, Sutterwala FS. 2009. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 21:194–198.
   PubMed Web of Science ®Google Scholar
• Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, Megson IL, Donaldson K. 2010. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 118:1699–1706.
   PubMed Web of Science ®Google Scholar
• Davis MJ, Swanson JA. 2010. Technical advance: Caspase-1 activation and IL-1ß release correlate with the degree of lysosome damage, as illustrated by a novel imaging method to quantify phagolysosome damage. J Leukoc Biol 88:813–822.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. 2011. Blocking interleukin-1ß in acute and chronic autoinflammatory diseases. J Intern Med 269:16–28.
   PubMed Web of Science ®Google Scholar
• Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677.
   PubMed Web of Science ®Google Scholar
• Drenth JP, van der Meer JW. 2006. The inflammasome–a linebacker of innate defense. N Engl J Med 355:730–732.
   PubMed Web of Science ®Google Scholar
• Fenoglio I, Tomatis M, Lison D, Muller J, Fonseca A, Nagy JB, Fubini B. 2006. Reactivity of carbon nanotubes: free radical generation or scavenging activity? Free Radic Biol Med 40:1227–1233.
   PubMed Web of Science ®Google Scholar
• Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, Schnyder B, Akira S, Quesniaux VF, Lagente V, Ryffel B, Couillin I. 2007. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 117:3786–3799.
   PubMed Web of Science ®Google Scholar
• Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. 2009. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol 6:35.
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, Stone V. 2010. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics. Nanotoxicology 4:207–246.
   PubMed Web of Science ®Google Scholar
• Kroeger KM, Sullivan BM, Locksley RM. 2009. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. J Leukoc Biol 86:769–778.
   PubMed Web of Science ®Google Scholar
• Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. 2006. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36:189–217.
   PubMed Web of Science ®Google Scholar
• Lanone S, Boczkowski J. 2006. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 6:651–663.
   PubMed Web of Science ®Google Scholar
• Lewinski N, Colvin V, Drezek R. 2008. Cytotoxicity of nanoparticles. Small 4:26–49.
   PubMed Web of Science ®Google Scholar
• Liang XJ, Chen C, Zhao Y, Jia L, Wang PC. 2008. Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab 9:697–709.
   PubMed Web of Science ®Google Scholar
• Liu XY, Gurel V, Morris D, Murray DW, Zhitkovich A, Kane AB, Hurt RH. 2007. Bioavailability of nickel in single-wall carbon nanotubes. Advanced Materials 19:2790.
   Web of Science ®Google Scholar
• Lu S, Duffin R, Poland C, Daly P, Murphy F, Drost E, Macnee W, Stone V, Donaldson K. 2009. Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ Health Perspect 117:241–247.
   PubMed Web of Science ®Google Scholar
• Martinon F, Mayor A, Tschopp J. 2009. The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265.
   PubMed Web of Science ®Google Scholar
• McNeilly JD, Heal MR, Beverland IJ, Howe A, Gibson MD, Hibbs LR, MacNee W, Donaldson K. 2004. Soluble transition metals cause the pro-inflammatory effects of welding fumes in vitro. Toxicol Appl Pharmacol 196:95–107.
   PubMed Web of Science ®Google Scholar
• Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW. 2010. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 7:28.
   PubMed Web of Science ®Google Scholar
• Murthy RC, Holovack MJ. 1991. Ultrastructural changes in rat lungs exposed to combinations of cadmium, zinc, copper, and nickel. J Submicrosc Cytol Pathol 23:289–293.
   PubMedGoogle Scholar
• Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–627.
   PubMed Web of Science ®Google Scholar
• Palomäki J, Välimäki E, Sund J, Vippola M, Clausen PA, Jensen KA, Savolainen K, Matikainen S, Alenius H. 2011. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5:6861–6870.
   PubMed Web of Science ®Google Scholar
• Poizot P, Laruelle S, Grugeon S, Dupont L, Tarascon JM. 2000. Nano-sized transition-metal oxides as negative-electrode materials for lithium-ion batteries. Nature 407:496–499.
   PubMed Web of Science ®Google Scholar
• Porter D, Wu N, Hubbs A, Mercer R, Funk K, Meng F, Li J, Wolfarth M, Battelli L, Friend S, Andrew M, Hamilton R, Sriram K, Yang F, Castranova V, Holian A. 2012. Differential mouse ulmonary dose- and time course- responses to titanium dioxide nanospheres and nanobelts. Toxicol Sciences. [E-pub ahead of print]
   PubMed Web of Science ®Google Scholar
• Pourahmad J, O’Brien PJ, Jokar F, Daraei B. 2003. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicol In Vitro 17:803–810.
   PubMed Web of Science ®Google Scholar
• Qu GB, Bai YH, Zhang Y, Jia Q, Zhang WD, Yan B. 2009. The effect of multiwalled carbon nanotube agglomeration on their accumulation in and damage to organs in mice. Carbon 47:2060–2069.
   Web of Science ®Google Scholar
• RNCOS. 2009. Nanotechnology market forecast to 2013 [Online]. Available: http://www.rncos.com/report/IM185.htm. Accessed 16 January 2010.
   Google Scholar
• Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289:L698–L708.
   PubMed Web of Science ®Google Scholar
• Tschopp J, Schroder K. 2010. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210–215.
   PubMed Web of Science ®Google Scholar
• Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77:117–125.
   PubMed Web of Science ®Google Scholar
• Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J. 2010. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1a and IL-1ß. Proc Natl Acad Sci USA 107:19449–19454.
   PubMed Web of Science ®Google Scholar